Showing results (21-30 of 153) with videos related to

Sort By:
Pageof 16
Case Reports in Oncology|September 6, 2012
Rituximab plus Ifosfamide, Carboplatin and Etoposide for T-Cell/Histiocyte-Rich B-Cell Lymphoma Arising in Nodular Lymphocyte-Predominant Hodgkin's LymphomaHyung-Chul Park, Sung-Hoon Jung, Jae-Sook Ahn, et al.
Journal of Korean Medical Science|December 6, 2007
Multiple intracranial tuberculomas mimicking granulocytic sarcomas in acute myeloid leukemiaJae Sook Ahn, Duk Hwan Yang, Yoe Kyeoung Kim, et al.
Biomed Research International|December 23, 2014
Clinical outcome of bortezomib retreatment in patients with relapsed or refractory multiple myelomaJae-Sook Ahn, Sung-Hoon Jung, Seung-Shin Lee, et al.
International Journal of Hematology|January 29, 2013
Lymphocytopenia is associated with an increased risk of severe infections in patients with multiple myeloma treated with bortezomib-based regimensSung-Hoon Jung, Soo-Young Bae, Jae-Sook Ahn, et al.
Annals of Hematology|December 7, 2013
Decreased body mass index is associated with poor prognosis in patients with multiple myelomaSung-Hoon Jung, Deok-Hwan Yang, Jae-Sook Ahn, et al.
Chonnam Medical Journal|January 9, 2015
OCT-1, ABCB1, and ABCG2 Expression in Imatinib-Resistant Chronic Myeloid Leukemia Treated with Dasatinib or NilotinibYeo-Kyeoung Kim, Seung-Shin Lee, Sung-Hoon Jeong, et al.
Biomed Research International|May 14, 2014
The impact of hyperglycemia on risk of severe infections during early period of induction therapy in patients with newly diagnosed multiple myelomaSung-Hoon Jung, Hee-Chang Jang, Seung-Shin Lee, et al.
Journal of Korean Medical Science|February 3, 2011
DNA methylation changes following 5-azacitidine treatment in patients with myelodysplastic syndromeHuong Thi Thanh Tran, Hee Nam Kim, Il-Kwon Lee, et al.
Annals of Hematology|March 4, 2018
Genome-wide genotype-based risk model for survival in core binding factor acute myeloid leukemia patientsSilvia Park, Hangseok Choi, Hee Je Kim, et al.
The Korean Journal of Internal Medicine|January 9, 2019
Clinical impact of anti-thymocyte globulin on survival and graft-versus-host disease in patients undergoing human leukocyte antigen mismatched allogeneic stem cell transplantationTaeyun Kim, Yunsuk Choi, Je-Hwan Lee, et al.
Pageof 16